ENXTAM:DSFIRChemicals
A Look At DSM-Firmenich (ENXTAM:DSFIR) Valuation After Dual Listing Plan And €500m Share Buyback
Why DSM-Firmenich’s Latest Moves Matter for Shareholders
DSM-Firmenich (ENXTAM:DSFIR) has drawn fresh attention after reporting 4% like for like sales growth, outlining a 2026 to 2028 action plan, announcing a dual listing on SIX, and launching a €500 million share buyback.
See our latest analysis for DSM-Firmenich.
The recent 5.1% 7 day share price return and 7.7% 30 day share price return suggest momentum is picking up again, even though the 1 year total shareholder return of 29.7% decline...